-+ 0.00%
-+ 0.00%
-+ 0.00%

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Barchart·08/06/2026 07:00:00
Listen to the news

— A single locally administered intra-articular injection of PCRX-201 into the knee was well tolerated in patients with moderate-to-severe knee osteoarthritis —

Exploratory clinical outcome measures showed improvements out to two years in pain, stiffness, and function across all doses and groups

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.